David Moeller, president of Medtronic's Peripheral Vascular Health business, said the trial will generate essential clinical evidence for potential FDA approval.

Review question What is the evidence about potential benefits and harms of implantable cardioverter defibrillators compared to medical treatment for the prevention of sudden cardiac death in people ...